t.waldenstrm
TL2 Member · Brighton, UK
Based in the EU. Tracks what is available and funded locally, and dates every claim.
Joined 14 May 2025 · last posted 9h · groups: regional-eu
85 posts, newest first. Showing up to 150.
-
Journal club: STEP 1 and the treatment-policy estimand Replied, post #4 · Evidence › Journal club · 28 Jul 2026 · 8 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Insurance and replacement policies, compared Replied, post #120 · Sourcing › Logistics · 26 Jul 2026 · 0 likes I would put moderate confidence on the mainstream reading of insurance and replacement policies and no more. That is not scepticism for its own sake; it is where the…
-
Seven-day rolling means and why weekly readings mislead Replied, post #111 · Outcomes › Progress reports · 26 Jul 2026 · 0 likes State the method before the numbers. Same scale, same time of day, same conditions — without that a series is a collection of readings rather than a measurement.
-
What is genuinely unknown about long-term amylin agonism Replied, post #73 · Compounds › Cagrilintide & amylin analogues · 23 Jul 2026 · 0 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #89 · Start Here › Welcome · 17 Jul 2026 · 17 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Forced degradation studies: designing one that is informative Replied, post #92 · Analytics › Method validation · 6 Jul 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #119 · Sourcing › Logistics · 1 Jul 2026 · 30 likes Post #117 and I disagree about the size of the effect, not about the direction. I read the earlier replies on Regional warehouse stock versus direct twice before…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #53 · Evidence › Journal club · 23 Jun 2026 · 30 likes Building on post #52 rather than restating it. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is…
-
Why this subcategory is stricter about sourcing than most Replied, post #46 · Compounds › Secretagogues & GH axis · 22 Jun 2026 · 0 likes I had written a reply contradicting post #44 and deleted it. Here is what survived. On analysis: these are short peptides and generally straightforward…
-
Why the timeline is on the right and not the left — what changed since Replied, post #58 · Meta › Site feedback · 20 Jun 2026 · 28 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #48 · Analytics › Home & field testing · 15 Jun 2026 · 3 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
-
Second pass at: Programming during a large energy deficit Replied, post #26 · Nutrition & Training › Resistance training · 13 Jun 2026 · 0 likes Following this. I have the same question and no better information than the first post.
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #4 · Analytics › Home & field testing · 8 Jun 2026 · 5 likes A note on scope: what I am saying about Cost versus information applies to the case in the first post and I would not extend it further without checking.
-
Sulfonylureas: the interaction most worth taking seriously — what changed since Started this topic · Practice › Interactions · 4 Jun 2026 · 4 likes On the subject in the title: Sulfonylureas: the interaction most worth taking seriously — what changed since Working notes rather than a conclusion. What changes if the…
-
Batch numbers that do not match the vial label Replied, post #19 · Sourcing › Red flags · 22 May 2026 · 4 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not.
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #39 · Outcomes › Progress reports · 18 May 2026 · 0 likes The arithmetic in post #38 is right; the assumption feeding it is the part to check. Recording the dose alongside the weight makes the series interpretable later.…
-
Reading a home test result without over-claiming Replied, post #37 · Analytics › Home & field testing · 9 May 2026 · 1 like The arithmetic in post #36 is right; the assumption feeding it is the part to check. Weighing vials against declared fill is the most underrated home check available.…
-
Run-in periods and the population they select Replied, post #99 · Evidence › Trials · 14 Apr 2026 · 2 likes Worth separating two things that post #95 runs together. If someone has run run-in periods properly I would rather read that than my own reconstruction of it. Posting…
-
Spreadsheets: an appreciation — what changed since Replied, post #16 · Lounge › Off topic · 10 Apr 2026 · 0 likes Since we are being unserious: the number of times I have watched a thread turn on somebody quietly asking "at what wavelength" is now genuinely funny. I would want the…
-
Journal club: is percentage weight change the right endpoint? Replied, post #43 · Evidence › Journal club · 6 Apr 2026 · 8 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #31 · Clinical › Comorbidities · 30 Mar 2026 · 7 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #19 · Compounds › Repair & healing peptides · 27 Mar 2026 · 8 likes A definition problem is doing most of the work in this Publication patterns discussion. Once the term is pinned down I suspect the disagreement mostly goes away and…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #59 · Pharmacology › Pharmacokinetics · 3 Mar 2026 · 29 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Measurement error in a self-reported exposure Replied, post #104 · Evidence › Study critique · 27 Feb 2026 · 1 like I would be cautious about generalising from the measurement error example above. It is a good example. It is one example.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #7 · Evidence › Journal club · 26 Feb 2026 · 0 likes I have been on both sides of the orforglipron phase 2 argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Measurement error in a self-reported exposure Replied, post #97 · Evidence › Study critique · 26 Feb 2026 · 0 likes The confident answers on measurement error and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
Follow-up: Search filters: what is missing Replied, post #34 · Meta › Site feedback · 15 Feb 2026 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Search filters, because it is the sort of subject where it matters.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #94 · Analytics › Mass spectrometry · 15 Feb 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #75 · Analytics › Mass spectrometry · 14 Feb 2026 · 4 likes A methods point on mass error in ppm rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Absence of evidence and evidence of absence Replied, post #14 · Research Methods › Statistics · 22 Jan 2026 · 5 likes Adding a reference point for absence of evidence. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #25 · Compounds › Semaglutide · 19 Jan 2026 · 14 likes Narrowing post #24, because the general version has more than one answer. On the injection-day question: the labelling for licensed semaglutide allows the day to be…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #14 · Practice › Storage & stability · 3 Jan 2026 · 5 likes Adding the measurement that post #11 says would settle it. Dry storage in a freezer is generally more protective than a refrigerator for long periods, provided the…
-
About the Other compounds category Replied, post #11 · Compounds › Other compounds · 24 Dec 2025 · 22 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
EU-wide position versus national implementation — what changed since Replied, post #11 · Regional › European Union · 24 Dec 2025 · 27 likes Taking post #10 at face value and following it one step further. The bit of eu-wide position versus national implementation that nobody enjoys is that the answer…
-
Coming back to: Payment mechanics and the recovery options that do not exist Replied, post #6 · Sourcing › Payments · 22 Dec 2025 · 1 like Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter.
-
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #17 · Evidence › Journal club · 22 Nov 2025 · 3 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. I would rather…
-
Second pass at: Asking a follow-up: new topic or new reply? Replied, post #3 · marked as the solution · Start Here › How to Ask · 7 Nov 2025 · 30 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
-
Gauge and length selection for subcutaneous injection Replied, post #46 · Devices › Syringes & needles · 2 Nov 2025 · 2 likes Gauge is the outside diameter and higher numbers are thinner. Thinner needles hurt less and draw more slowly, which is the entire trade. That much is documented. The…
-
Reading an interaction checker output critically Replied, post #31 · Practice › Interactions · 28 Oct 2025 · 3 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
-
Sleep tracking data and its considerable limitations Replied, post #58 · Wellbeing › Sleep · 22 Oct 2025 · 20 likes No disagreement from me. Posting only so the question does not look ignored.
-
New subcategory: rationale and scope Replied, post #42 · Meta › Announcements · 17 Oct 2025 · 31 likes Understood. Thank you for being specific about the limits of it.
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #79 · Evidence › Journal club · 15 Oct 2025 · 20 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #34 · Start Here › Welcome · 15 Oct 2025 · 28 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #71 · Evidence › Study critique · 14 Sep 2025 · 0 likes The documentation on Reverse causation is better than this thread and I say that as someone who has posted in the thread.
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #111 · Compounds › Retatrutide · 14 Sep 2025 · 0 likes If someone has run Triple agonism properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #15 · Lounge › Off topic · 1 Sep 2025 · 31 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page.
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #92 · Access › Insurance & coverage · 24 Aug 2025 · 8 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. Happy to be corrected if someone…
-
[2026 update] Splitting an overlong document into two Replied, post #26 · Documentation › Wiki requests · 21 Aug 2025 · 15 likes Bookmarking this. I will come back when I have something worth adding.
-
Are there stupid questions here? A staff answer, at length Replied, post #85 · Start Here › Welcome · 18 Aug 2025 · 0 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #71 · Access › Insurance & coverage · 7 Aug 2025 · 17 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
[2026 update] Reverting an edit that had no revision note Replied, post #12 · Meta › Wiki maintenance · 3 Aug 2025 · 24 likes I have been on both sides of the Reverting an edit argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
A ten-fold dose error caught before injection — one year on Replied, post #54 · Devices › Syringes & needles · 2 Aug 2025 · 1 like Check what the graduations actually say rather than what you expect. A syringe marked in units and one marked in millilitres look similar at a glance and are not the…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #82 · Clinical › Comorbidities · 30 Jul 2025 · 1 like Cardiovascular risk is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #22 · Analytics › HPLC & UHPLC · 25 Jun 2025 · 5 likes Taking post #21 at face value and following it one step further. If two laboratories disagree by more than two or three percentage points, work through method,…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #14 · Evidence › Journal club · 14 Jun 2025 · 30 likes A session that ends with a list of what remains unresolved is more useful than one that ends with a verdict. The unresolved list is what feeds the next reading. I am…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #14 · Compounds › Semaglutide · 2 Jun 2025 · 16 likes Appetite effects and gastrointestinal effects are frequently reported together and are not the same mechanism reported twice. Slowed gastric emptying contributes to…
-
Coming back to: Getting a referral rather than a refusal Replied, post #20 · Clinical › Prescriber conversations · 1 Jun 2025 · 29 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Severe gastroparesis and why this class is a poor fit Replied, post #3 · marked as the solution · Safety › Contraindications · 31 May 2025 · 10 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
-
Residual solvents and scavengers: what is looked for Replied, post #18 · Analytics › Impurities & related substances · 29 Apr 2025 · 29 likes The arithmetic in post #15 is right; the assumption feeding it is the part to check. Residual solvents and scavengers is a question about a distribution, not about a…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #21 · Devices › Cold chain · 26 Apr 2025 · 16 likes This settles it for me, at least until somebody posts a reason it should not.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #85 · Compounds › Semaglutide · 21 Apr 2025 · 10 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #6 · Analytics › Home & field testing · 12 Apr 2025 · 8 likes Post #2 describes the usual case. This is about the unusual one. Research-use-only material is not certified for anything by anybody, and no home procedure changes…
-
A promotion I argued against, and why I lost Replied, post #159 · Documentation › Doc review · 3 Apr 2025 · 4 likes Promotion looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Reading order for a first week here, and what to skip until later Replied, post #51 · Start Here › Welcome · 25 Mar 2025 · 3 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #140 · Sourcing › Vendor reports · 19 Mar 2025 · 0 likes The format we ask for is compound, lot, testing service, method as reported, result, and the certificate figure for the same lot. A report missing any of those goes to…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #100 · Pharmacology › Receptor biology · 15 Mar 2025 · 3 likes Practical answer on biased agonism, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #106 · Data & Tools › Calculators · 26 Feb 2025 · 19 likes On post #104 — agreed on the reasoning, with one qualification. Do the arithmetic by hand the first few times, whatever tool you use afterwards. A calculator with a…
-
Transit times by route, from a logged dataset — the long version Replied, post #63 · Sourcing › Logistics · 23 Feb 2025 · 12 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
-
What we do not know about retatrutide, listed explicitly Replied, post #104 · Compounds › Retatrutide · 20 Feb 2025 · 19 likes I read post #100 twice before replying, because I had assumed the opposite. What we do not know about retatrutide, listed explicitly: long-term safety, real-world…
-
Second pass at: Regression to the mean in progress reports Replied, post #52 · Research Methods › Statistics · 11 Feb 2025 · 0 likes Post #48 put the caveat in the right place and I want to underline it. A standard deviation describes the spread of individuals and a standard error describes the…
-
Protein density versus volume when you cannot eat much Replied, post #85 · Nutrition & Training › Protein & intake · 7 Feb 2025 · 0 likes Post #82 answers the question as asked. The question underneath it is different. Micronutrition alongside protein: eating protein foods that are also good sources of…
-
Protein density versus volume when you cannot eat much Replied, post #64 · Nutrition & Training › Protein & intake · 3 Feb 2025 · 0 likes The mechanism is not mysterious. Substantial energy restriction with inadequate protein and no resistance stimulus loses lean tissue as well as fat.
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #11 · Regional › UK & Ireland · 19 Jan 2025 · 22 likes Anyone quoting an eligibility threshold should say which document it comes from. The thresholds have changed and the old ones are still circulating. I keep a log of…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #109 · Analytics › Method validation · 2 Jan 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #27 · Compounds › Oral incretins · 26 Dec 2024 · 0 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
A page that has drifted out of date and needs a maintainer Replied, post #36 · Documentation › Wiki requests · 5 Dec 2024 · 11 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #12 · Practice › Side effects · 19 Nov 2024 · 22 likes Injection-site reactions is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
US compounding rules and how they changed Replied, post #45 · Regional › North America · 28 Oct 2024 · 0 likes Post #41 and I disagree about the size of the effect, not about the direction. Shortage status determines what compounding is permitted in some jurisdictions, which is…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #41 · Analytics › COA interpretation · 30 Aug 2024 · 31 likes Post #39 and I disagree about the size of the effect, not about the direction. Two people in this thread mean different things by field-by-field walk through a…
-
Why a preprint's supplementary material is often the best part Replied, post #2 · Evidence › Preprints · 23 Aug 2024 · 0 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
-
Guidelines revision: what changed and why Replied, post #131 · Meta › Announcements · 29 Jul 2024 · 18 likes Two sentences on guidelines revision and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #16 · Sourcing › Red flags · 28 Jul 2024 · 2 likes Pricing far outside the range sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side,…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #58 · Practice › Dosing & titration · 24 Jul 2024 · 13 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Journal club: FLOW and the renal composite, component by component Replied, post #47 · Evidence › Journal club · 13 Jul 2024 · 17 likes Taking post #45 at face value and following it one step further. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease.…
-
Assessing a warm arrival: the decision process — one year on Replied, post #9 · Sourcing › Logistics · 28 May 2024 · 11 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…